Active, not recruiting
A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity
NCT07310901
- Conditions
- Body Weight, Endocrine System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Central Alabama Research Birmingham, Alabama, United States
- Arizona Clinical Trials Chandler, Arizona, United States
- Prospective Research Innovations Rancho Cucamonga, California, United States
- Accel Research Sites DeLand, Florida, United States